Literature DB >> 9430364

Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis.

R M Fisher1, S E Humphries, P J Talmud.   

Abstract

The importance of the enzyme lipoprotein lipase (LPL) in the development of dyslipidaemia and atherosclerosis is increasingly recognised. Variations in the LPL gene which are common in the general population have been shown to be associated with alterations in plasma lipids. D9N and N291S both occur at carrier frequencies of up to about 5% and have been associated with increased plasma triacylglycerol and decreased high density lipoprotein cholesterol concentrations, effects which seem to be magnified in more obese individuals. S447X carrier frequency is approximately 20%, but unlike carriers of N9 or S291, X447 carriers appear to have a more favourable lipid profile. A transition within the LPL promoter at position-93 may lead to increased LPL activity and have a beneficial effect on plasma lipids. Greater knowledge of the underlying mechanisms of these variations within the LPL gene may be of considerable importance in understanding genetic predisposition to atherosclerosis and heart disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430364     DOI: 10.1016/s0021-9150(97)00199-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Recombinational and mutational hotspots within the human lipoprotein lipase gene.

Authors:  A R Templeton; A G Clark; K M Weiss; D A Nickerson; E Boerwinkle; C F Sing
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  APOC3 promoter polymorphisms C-482T and T-455C are associated with the metabolic syndrome.

Authors:  Michael Miller; Jeffrey Rhyne; Hegang Chen; Valerie Beach; Richard Ericson; Kalpana Luthra; Manjari Dwivedi; Anoop Misra
Journal:  Arch Med Res       Date:  2007-03-26       Impact factor: 2.235

Review 4.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

5.  The -93T/G LPL Promoter Polymorphism Is Associated With Lower Third-Trimester Triglycerides in Pregnant African American Women.

Authors:  Mandy J Schmella; Robert E Ferrell; Marcia J Gallaher; David L Lykins; Andrew D Althouse; James M Roberts; Carl A Hubel
Journal:  Biol Res Nurs       Date:  2015-01-07       Impact factor: 2.522

6.  Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23.

Authors:  E N Kort; D G Ballinger; W Ding; S C Hunt; B R Bowen; V Abkevich; K Bulka; B Campbell; C Capener; A Gutin; K Harshman; M McDermott; T Thorne; H Wang; B Wardell; J Wong; P N Hopkins; M Skolnick; M Samuels
Journal:  Am J Hum Genet       Date:  2000-04-17       Impact factor: 11.025

Review 7.  Endoplasmic reticulum quality control in lipoprotein metabolism.

Authors:  Cari M Koerner; Benjamin S Roberts; Saskia B Neher
Journal:  Mol Cell Endocrinol       Date:  2019-08-20       Impact factor: 4.102

8.  The S447X variant of lipoprotein lipase gene is inversely associated with severity of coronary artery disease.

Authors:  Mehmet Agirbasli; Mutlu Cagan Sumerkan; Fatih Eren; Deniz Agirbasli
Journal:  Heart Vessels       Date:  2010-12-03       Impact factor: 2.037

9.  Lipoprotein lipase gene sequencing and plasma lipid profile.

Authors:  Dilek Pirim; Xingbin Wang; Zaheda H Radwan; Vipavee Niemsiri; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Lipid Res       Date:  2013-11-09       Impact factor: 5.922

10.  Lipid and endothelium-related genes, ambient particulate matter, and heart rate variability--the VA Normative Aging Study.

Authors:  C Ren; A Baccarelli; E Wilker; H Suh; D Sparrow; P Vokonas; R Wright; J Schwartz
Journal:  J Epidemiol Community Health       Date:  2010-01       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.